Literature DB >> 32634502

Mechanisms of Cav3-associated arrhythmia: Protein or microdomain dysfunction?

Antonio Zaza1, Eleonora Grandi2.   

Abstract

Entities:  

Keywords:  Caveolin-3; LQTS

Year:  2020        PMID: 32634502      PMCID: PMC7577955          DOI: 10.1016/j.ijcard.2020.06.051

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  17 in total

1.  Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling.

Authors:  Claire E Sears; Simon M Bryant; Euan A Ashley; Craig A Lygate; Stevan Rakovic; Helen L Wallis; Stefan Neubauer; Derek A Terrar; B Casadei
Journal:  Circ Res       Date:  2003-03-06       Impact factor: 17.367

2.  Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.

Authors:  Matteo Vatta; Michael J Ackerman; Bin Ye; Jonathan C Makielski; Enoh E Ughanze; Erica W Taylor; David J Tester; Ravi C Balijepalli; Jason D Foell; Zhaohui Li; Timothy J Kamp; Jeffrey A Towbin
Journal:  Circulation       Date:  2006-10-23       Impact factor: 29.690

3.  Discovery and characterization of a monogenetic insult, caveolin-3-V37L, that precipitated oligo-proteomic perturbations governing repolarization reserve.

Authors:  Dan Ye; Wei Zhou; David J Tester; Michael J Ackerman
Journal:  Int J Cardiol       Date:  2020-05-06       Impact factor: 4.164

4.  Cell surface expression of human ether-a-go-go-related gene (hERG) channels is regulated by caveolin-3 protein via the ubiquitin ligase Nedd4-2.

Authors:  Jun Guo; Tingzhong Wang; Xian Li; Heidi Shallow; Tonghua Yang; Wentao Li; Jianmin Xu; Michael D Fridman; Xiaolong Yang; Shetuan Zhang
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

5.  The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1: physiology and pathology related to long qt syndrome 9 (LQT9).

Authors:  Ravi Vaidyanathan; Amanda L Vega; Chunhua Song; Qing Zhou; Bi-Hua Tan; Bihua Tan; Stuart Berger; Jonathan C Makielski; Lee L Eckhardt
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

6.  Long QT syndrome caveolin-3 mutations differentially modulate Kv 4 and Cav 1.2 channels to contribute to action potential prolongation.

Authors:  Leonid Tyan; Jason D Foell; Kevin P Vincent; Marites T Woon; Walatta T Mesquitta; Di Lang; Jabe M Best; Michael J Ackerman; Andrew D McCulloch; Alexey V Glukhov; Ravi C Balijepalli; Timothy J Kamp
Journal:  J Physiol       Date:  2019-01-24       Impact factor: 5.182

7.  Caveolin-3 associates with developing T-tubules during muscle differentiation.

Authors:  R G Parton; M Way; N Zorzi; E Stang
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

8.  Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling.

Authors:  Peter T Wright; Viacheslav O Nikolaev; Thomas O'Hara; Ivan Diakonov; Anamika Bhargava; Sergiy Tokar; Sophie Schobesberger; Andrew I Shevchuk; Markus B Sikkel; Ross Wilkinson; Natalia A Trayanova; Alexander R Lyon; Sian E Harding; Julia Gorelik
Journal:  J Mol Cell Cardiol       Date:  2013-12-15       Impact factor: 5.000

9.  Characterization of the molecular architecture of human caveolin-3 and interaction with the skeletal muscle ryanodine receptor.

Authors:  Gareth Whiteley; Richard F Collins; Ashraf Kitmitto
Journal:  J Biol Chem       Date:  2012-10-15       Impact factor: 5.157

10.  Identification and functional analysis of a new putative caveolin-3 variant found in a patient with sudden unexplained death.

Authors:  Vincenzo Lariccia; Annamaria Assunta Nasti; Federica Alessandrini; Mauro Pesaresi; Santo Gratteri; Adriano Tagliabracci; Salvatore Amoroso
Journal:  J Biomed Sci       Date:  2014-06-10       Impact factor: 8.410

View more
  1 in total

Review 1.  The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease.

Authors:  Mengru Wang; Xin Tu
Journal:  Front Cardiovasc Med       Date:  2022-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.